MedPath

Ephedrine

Generic Name
Ephedrine
Brand Names
Akovaz, Bronkaid, Corphedra, Emerphed, Primatene, Rezipres
Drug Type
Small Molecule
Chemical Formula
C10H15NO
CAS Number
299-42-3
Unique Ingredient Identifier
GN83C131XS
Background

Ephedrine was first described in western literature in 1888, as a naturally occurring component of the ephedra plant, along with pseudoephedrine. Ephedrine acts as both a direct and indirect sympathomimetic. It is an alpha- and beta-adrenergic receptor agonist; however, it also causes the indirect release of norepinephrine from sympathetic neurons, inhibiting norepinephrine reuptake and displacing more norepinephrine from storage vesicles. Ephedrine is used for its vasoconstrictive, positive chronotropic, and positive inotropic effects. Ephedrine and phenylephrine are still used to treat hypotension, but their use in other indications has decreased due to the development of more selective adrenergic agonists. Ephedrine was granted a type 7 FDA Approval on 29 April 2016.

Indication

Ephedrine intravenous injections are indicated to treat hypotension under anesthesia, ephedrine injections by multiple routes are indicated to treat allergic conditions such as bronchial asthma, ephedrine nasal spray is and OTC medication used as a decongestant.

Associated Conditions
Allergic Reaction, Bronchial Asthma, Common Cold, Cough, Depression, Fever, General Anesthesia Induced Hypotension, Headache, Joint Pain, Myasthenia Gravis, Narcolepsy, Nasal Congestion, Rhinorrhoea, Sore Throat, Dry cough
Associated Therapies
-

Ephedrine Versus Phenylephrine for Spinal Block - Related Hypotension in Cesarean Delivery

Not yet recruiting
Conditions
Spinal Anesthesia
Cesarean Delivery
Neonatal Acidosis
Interventions
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
Centre of Postgraduate Medical Education
Target Recruit Count
80
Registration Number
NCT06741410
Locations
🇵🇱

Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care, Warsaw, Poland

Ephedrine Doses to Prevent Maternal Hypotension After Spinal Anesthesia in Cesarean Section

Phase 4
Completed
Conditions
Hypotension After Spinal Anesthesia
Hypotension During Cesarean Delivery
Interventions
Drug: Normal Saline (Placebo)
Drug: Ephedrine
First Posted Date
2024-10-31
Last Posted Date
2024-10-31
Lead Sponsor
B.P. Koirala Institute of Health Sciences
Target Recruit Count
120
Registration Number
NCT06668337
Locations
🇳🇵

B.P. koirala Institute of Health Sciences, Dharan, Nepal

Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine

Not Applicable
Recruiting
Conditions
Anesthesia Complication
Vasopressor
Cesarean Section Complications
Hypotension During Surgery
Interventions
First Posted Date
2024-07-12
Last Posted Date
2024-10-23
Lead Sponsor
Hopital Charles Nicolle
Target Recruit Count
126
Registration Number
NCT06498076
Locations
🇹🇳

Charles Nicolle Hospital, Tunis, Tunisia

Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.

Phase 2
Recruiting
Conditions
Dexmedetomidine
Intubation Complication
Interventions
First Posted Date
2024-03-25
Last Posted Date
2024-03-25
Lead Sponsor
Kasr El Aini Hospital
Target Recruit Count
70
Registration Number
NCT06327399
Locations
🇪🇬

Cairo University Hospitals, Giza, Egypt

Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study

Not Applicable
Recruiting
Conditions
Postpartum Hemorrhage
Interventions
First Posted Date
2024-02-29
Last Posted Date
2024-04-12
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
24
Registration Number
NCT06285396
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Could Ephedrine Replace Dexmedetomidine Fordexmedetomidine Prevention of Shivering in Women Undergoing Cesarean Section Under Spinal Anaesthesia

Not Applicable
Recruiting
Conditions
Prevention of Shivering With Spinal Anaesthesia
Interventions
First Posted Date
2024-01-31
Last Posted Date
2024-01-31
Lead Sponsor
Assiut University
Target Recruit Count
200
Registration Number
NCT06233032
Locations
🇪🇬

Assiut university, Assiut, Egypt

Cerebral Flow-metabolism Coupling During Adult Surgery

Phase 4
Recruiting
Conditions
Anesthesia
Interventions
First Posted Date
2023-07-12
Last Posted Date
2023-10-18
Lead Sponsor
Jason Chui
Target Recruit Count
80
Registration Number
NCT05941494
Locations
🇨🇦

London Health Sciences Centre, London, Ontario, Canada

The Effect of Low-dose Atropine on Sympathetic Blockade in Spinal Cesarean Section Patients

Phase 4
Completed
Conditions
Anesthesia, Spinal
Pregnancy
Cesarean Section
Interventions
Drug: Slow dose preemptive Atropine
Drug: Ephedrine
First Posted Date
2023-06-07
Last Posted Date
2023-10-11
Lead Sponsor
Abant Izzet Baysal University
Target Recruit Count
60
Registration Number
NCT05892913
Locations
🇹🇷

Bolu Abant Izzet Baysal university Medical School, Anesthesiology and Reanimation D., Bolu, Turkey

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

Phase 4
Recruiting
Conditions
Labor
Interventions
Drug: Normal Saline Placebo
Drug: Ephedrine
First Posted Date
2023-05-24
Last Posted Date
2024-05-08
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
150
Registration Number
NCT05873218
Locations
🇺🇸

Icahn School of Medicine at Mount SInai, New York, New York, United States

Intubation Conditions After RSI Using Rocuronium with Ephedrine Pretreatment

Phase 3
Completed
Conditions
Rapid Sequence Induction and Intubation
Interventions
First Posted Date
2023-02-13
Last Posted Date
2024-10-14
Lead Sponsor
Ain Shams University
Target Recruit Count
75
Registration Number
NCT05725031
Locations
🇪🇬

Ain Shams University Hospitals, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath